Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MPTP toxicity: clinical features.

A Williams

    Journal of Neural Transmission. Supplementum
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induces Parkinsonism in humans, offering a precise model for idiopathic Parkinson's disease research. This chemical model is superior to previous models using other toxins or viruses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Myocardial abscess: an unusual complication of long-term hemodialysis line presence.

    Clinical nephrology·1999
    Same author

    "One-stop" surgery: implications for anesthesiologists of an expedited pediatric surgical process.

    Southern medical journal·1999
    Same author

    Calculating the global burden of disease: time for a strategic reappraisal?

    Health economics·1999
    Same author

    Aerosol route enhances the contamination of intact eggs and muscle of experimentally infected laying hens by Salmonella typhimurium DT104.

    FEMS microbiology letters·1999
    Same author

    Short gastric artery perforation after use of 'ecstasy'.

    Journal of the Royal Society of Medicine·1999
    Same author

    Meniscal movement. An in-vivo study using dynamic MRI.

    The Journal of bone and joint surgery. British volume·1999
    Same journal

    Intake of tomato-enriched diet protects from 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons.

    Journal of neural transmission. Supplementum·2010
    Same journal

    A diet for dopaminergic neurons?

    Journal of neural transmission. Supplementum·2010
    Same journal

    Immunization as treatment for Parkinson's disease.

    Journal of neural transmission. Supplementum·2010
    Same journal

    Gene therapy for Parkinson's disease.

    Journal of neural transmission. Supplementum·2010
    Same journal

    Stem cells and cell replacement therapy for Parkinson's disease.

    Journal of neural transmission. Supplementum·2010
    Same journal

    Neurogenesis in substantia nigra of parkinsonian brains?

    Journal of neural transmission. Supplementum·2010
    See all related articles

    Area of Science:

    • Neuroscience
    • Toxicology
    • Neurology

    Background:

    • Parkinson's disease is a neurodegenerative disorder characterized by motor deficits.
    • Existing chemical models for Parkinson's disease have limitations in accurately replicating the human condition.

    Purpose of the Study:

    • To evaluate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a model for idiopathic Parkinson's disease.
    • To compare the efficacy of MPTP as a Parkinson's disease model against other chemical or viral models.

    Main Methods:

    • Administration of MPTP to human subjects.
    • Clinical assessment of induced Parkinsonian symptoms.
    • Comparison of MPTP-induced symptoms with idiopathic Parkinson's disease.

    Main Results:

    Related Experiment Videos

    • MPTP caused acute and irreversible Parkinsonism in humans.
    • The induced condition precisely mimicked idiopathic Parkinson's disease.
    • MPTP-induced Parkinsonism was more accurate than models from other chemicals or viruses.

    Conclusions:

    • MPTP is a highly accurate and effective model for studying idiopathic Parkinson's disease.
    • This model provides a valuable tool for research into Parkinson's disease pathogenesis and treatment.